Searched for
PAR PHARMACEUTICAL
Stock picks of the week: 5 stocks with consistent score improvement and upside potential of up to 27% in 1 yearAfter the correction, the street will reach a stage where, if a company delivers numbers, there will be enough money waiting to move into t...- Organon gives Sun Pharma scale and reach, but challenge lies in integration, executionSun Pharma has acquired Organon & Co for $11.75 billion. This deal provides Sun Pharma with expanded global scale and commercial reach. It ...
- Koye Pharma next on Warburg's health playGlobal private equity fund Warburg Pincus is nearing a deal to buy Koye Pharma. The Mumbai-based drugmaker focuses on women's health, respi...
- Niti to review concerns over pharma qualityNiti Aayog is addressing growing quality concerns in India's pharmaceutical industry by convening industry experts for discussions. The aim...
- Buy Akums Drugs & Pharmaceuticals, target price Rs 710: ICICI SecuritiesICICI Securities has given a buy call for Akums Drugs & Pharmaceuticals with a target price of Rs 710, citing profitable growth potential. ...
- Dr Reddy's launches authorised generic of Vasostrict injection“We are pleased to provide this important authorized generic product to patients, especially in these difficult times of COVID-19,” says Ma...
- TPG Capital to buy into Sai Life SciencesTPG will acquire the 33% stake held by Tata Capital and pump in some fresh money into the company in the form of growth capital, sources sa...
- Glenmark launches generic version of Zetia in US market"We have launched ezetimibe, the first and only generic version of Zetia (Merck) in the United States for the treatment of high cholesterol...
- GAVIS Pharma LLC looking to exit Bengaluru-based Wintac LtdGavis Pharma LLC is now exploring options to exit its listed Indian arm. Wintac Ltd was not part of the 2015 deal struck between Lupin & Ga...
- Dr Reddy's, Sun Pharma among 14 firms probed by US Congress over drug price"When you see how much the prices of these drugs have increased just over the past year, it's staggering, and we want to know why," said Cu...
- Settlement of Somaxon Pharmaceuticals patent suit in US soon: ZydusAhmedabad-based Zydus Cadila says, it agreed to settle a patent litigation suit with US-based Somaxon Pharmaceuticals for insomnia drug – S...
- US Food and Drug Administration approves generic versions of schizophrenia drugUS Food and Drug Administration (FDA) has approved the first generic versions of Zyprexa and Zyprexa Zydus, used for treating schizophrenia...
- Merck, Glenmark end cholesterol drug rowCos opt for out-of-court settlement; Merck to refund $20-mn litigation costs.
- Glenmark inks licence, supply pact with TaroGlenmark Pharmaceuticals on Thursday said it has signed a licence and supply agreement with Israeli firm Taro Pharmaceuticals to sell a bra...
- Glenmark takes patent cover with drug dealGlenmark Pharmaceuticals issued exclusive marketing rights for cholesterol control ezetimibe to another generic company Par Pharmaceutical ...
- Glenmark in licensing deal with US co for cholesterol drugDrug firm Glenmark on Tuesday said it has signed an exclusive licensing agreement with the US-based Par Pharmaceutical to sell generic chol...
- GSK enters into agreement with Japan-based Astellas PharmaDrug firm GlaxoSmithkline Pharmaceuticals on Monday said it has enter into a collaboration with the Japan-based Astellas Pharma Inc for sel...
- Dr Reddy's in race for US Par PharmaDr Reddy’s Laboratories is in the race with three other Indian drug majors to acquire US-based generic drug maker Par Pharma.
- Indian drug makers eye US firm Par PharmaIndia's top drug makers are in the race to acquire US-based generic drug maker, Par Pharmaceutical Co Inc, two Indian newspapers reported o...
- Indian drug cos eye US' Par PharmaLeading Indian drug makers, including Ranbaxy Laboratories, Wockhardt and Sun Pharma, are believed to be in the fray for acquiring Par Phar...
Load More
